At a glance
ClinicalIndex Comparison RecordN/ACompleted· 104 enrolled
Drug / intervention
Progestins Norethindrone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness of Hormonal Intrauterine Device in Treating Pelvic Congestion Syndrome Compared to Oral Progestin
In Brief
A clinical study evaluating Hormonal intrauterine device and Progestins Norethindrone for Pelvic Congestion. Completed, enrolled 104 participants across 1 site.
Detailed Summary
The aim of this study is to compare the effectiveness of hormonal intrauterine device (IUD) in treatment of pelvic congestion syndrome in comparison with oral progestins treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPelvic Congestion
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedSep 2021
Enrollment StartDec 2021
Primary CompletionDec 2022
Study CompletionFeb 2023
TodayJul 2026
First PostedSep 20, 2021
Enrollment StartDec 1, 2021
Primary CompletionDec 31, 2022
Study CompletionFeb 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.8 years ago
Interventions
Hormonal intrauterine devicedevice
insertion of hormonal IUD during menstrual period
Progestins Norethindronedrug
oral ethisteron twice daily for three months